These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 37965055)

  • 21. Identification and validation of molecular subtype and prognostic signature for lung adenocarcinoma based on neutrophil extracellular traps.
    Zuo Y; Leng G; Leng P
    Pathol Oncol Res; 2023; 29():1610899. PubMed ID: 37143472
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification and validation of a novel cuproptosis-related signature as a prognostic model for lung adenocarcinoma.
    Chen Y; Tang L; Huang W; Zhang Y; Abisola FH; Li L
    Front Endocrinol (Lausanne); 2022; 13():963220. PubMed ID: 36353226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Construction and experimental validation of a necroptosis-related lncRNA signature as a prognostic model and immune-landscape predictor for lung adenocarcinoma.
    Zhang T; Hei R; Huang Y; Shao J; Zhang M; Feng K; Qian W; Li S; Jin F; Chen Y
    Am J Cancer Res; 2023; 13(9):4418-4433. PubMed ID: 37818057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel defined risk signature of cuproptosis-related long non-coding RNA for predicting prognosis, immune infiltration, and immunotherapy response in lung adenocarcinoma.
    Ma C; Li F; Gu Z; Yang Y; Qi Y
    Front Pharmacol; 2023; 14():1146840. PubMed ID: 37670938
    [No Abstract]   [Full Text] [Related]  

  • 25. Relationships of N6-Methyladenosine-Related Long Non-Coding RNAs With Tumor Immune Microenvironment and Clinical Prognosis in Lung Adenocarcinoma.
    Zhao J; Lin X; Zhuang J; He F
    Front Genet; 2021; 12():714697. PubMed ID: 34777460
    [No Abstract]   [Full Text] [Related]  

  • 26. Establishment of lung adenocarcinoma classification and risk model based on necroptosis-related genes.
    Wu G; Feng D; Zhang Z; Zhang G; Zhang W
    Front Genet; 2022; 13():1037011. PubMed ID: 36452156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel glycosylation-related gene signature predicts survival in patients with lung adenocarcinoma.
    Liang JX; Chen Q; Gao W; Chen D; Qian XY; Bi JQ; Lin XC; Han BB; Liu JS
    BMC Bioinformatics; 2022 Dec; 23(1):562. PubMed ID: 36575396
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification and Verification of Necroptosis-Related Gene Signature and Associated Regulatory Axis in Breast Cancer.
    Hu T; Zhao X; Zhao Y; Cheng J; Xiong J; Lu C
    Front Genet; 2022; 13():842218. PubMed ID: 35251139
    [No Abstract]   [Full Text] [Related]  

  • 29. A cuproptosis-related lncRNA signature for predicting prognosis and immunotherapy response of lung adenocarcinoma.
    Yu S; Tang L; Zhang Q; Li W; Yao S; Cai Y; Cheng H
    Hereditas; 2023 Jul; 160(1):31. PubMed ID: 37482612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction of a prognostic model for lung adenocarcinoma based on membrane-tension-related genes.
    Zhu P; Teng Z; Yang W; Zhang D; Wang B; Yang Z; Wang K; Pu J
    J Thorac Dis; 2023 Apr; 15(4):2098-2115. PubMed ID: 37197492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
    Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
    Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel cuproptosis-related lncRNA signature to predict prognosis and immune landscape of lung adenocarcinoma.
    Wang X; Jing H; Li H
    Transl Lung Cancer Res; 2023 Feb; 12(2):230-246. PubMed ID: 36895935
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A novel necroptosis related gene signature and regulatory network for overall survival prediction in lung adenocarcinoma.
    Wang G; Liu X; Liu H; Zhang X; Shao Y; Jia X
    Sci Rep; 2023 Sep; 13(1):15345. PubMed ID: 37714937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apoptosis-Related Signature Predicts Prognosis and Immune Microenvironment Infiltration in Lung Adenocarcinoma.
    Zou X; He R; Zhang Z; Yan Y
    Front Genet; 2022; 13():818403. PubMed ID: 35571020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
    Tian Q; Zhou Y; Zhu L; Gao H; Yang J
    Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
    [No Abstract]   [Full Text] [Related]  

  • 37. Identification of CDT1 as a prognostic marker in human lung adenocarcinoma using bioinformatics approaches.
    Jiang J; Zhang Y; Wang J; Yang X; Ren X; Huang H; Wang J; Lu J; Zhong Y; Lin Z; Lin X; Jia Y; Lin S
    PeerJ; 2023; 11():e16166. PubMed ID: 37790630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
    Li W; Liu S; Su S; Chen Y; Sun G
    PeerJ; 2021; 9():e10470. PubMed ID: 33510968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma.
    Lin L; Zhang W
    Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel anoikis-related gene signature to predict the prognosis, immune infiltration, and therapeutic outcome of lung adenocarcinoma.
    Wang Y; Xie C; Su Y
    J Thorac Dis; 2023 Mar; 15(3):1335-1352. PubMed ID: 37065587
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.